Canadian Hemophilia Society

Novel Therapies for Bleeding Disorders

Health EN ↓ 4 episodes

Innovation is accelerating—not only in communications, computer technology, and artificial intelligence, but also in medical science. For people living with inherited bleeding disorders, this acceleration is transforming what is possible. Over the past decade, treatment advances have reshaped care. Extended half-life factor VIII and IX concentrates have reduced infusion frequency. Factor VIII mimetics such as emicizumab have introduced entirely new mechanisms of action. The first gene therapies for hemophilia A and B are now a reality. Rebalancing agents have entered the therapeutic landscape....

Author

Canadian Hemophilia Society

Episodes

Maladie de Von Willebrand et Thrombasthénie de Glanzmann 17.02.2026 24:24

Dans ce balado, DR ROY KHALIFÉ nous parlera des traitements qui pourraient être accessibles à l'avenir pour traiter la maladie de von Willebrand et la thrombasthénie de Glanzmann, des maladies qui n'ont pas bénéficié jusqu'à présent des progrès de la recherche clinique autant que l’hémophilie A et B. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com...

VWD and Glanzmann Thrombasthenia 17.02.2026 22:06

In this episode, DR. ROY KHALIFÉ will explore therapies that may become available in the future to treat von Willebrand disease and Glanzmann Thrombasthenia, conditions that have not benefitted from clinical research advances to the same degree as hemophilia A and B until now. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-...

Prochains Traitements Sur le Marché Canadien 17.02.2026 25:08

Dans ce balado, DR ROY KHALIFÉ, professeur adjoint à l'Université d'Ottawa et codirecteur du Programme régional d'Ottawa pour les troubles de la coagulation chez les adultes à l'Hôpital d'Ottawa, nous parlera de traitements pour différents troubles de la coagulation qui pourraient être accessibles au Canada au cours des deux ou trois prochaines années. See Privacy Policy at https://art19.com/priva...

Next Therapies on the Canadian Market 16.02.2026 22:38

In this episode, DR. ROY KHALIFÉ, Assistant Professor at the University of Ottawa and co-director of the Ottawa Regional Adult Bleeding Disorders Program at the Ottawa Hospital, will explore therapies for various bleeding disorders that have the potential to be available in Canada in the next couple of years. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://...